CVS Health Corp (NYSE:CVS) shares shot up 5.7% during trading on Tuesday after the company announced better than expected quarterly earnings. The company traded as high as $78.09 and last traded at $77.90. 12,827,852 shares changed hands during mid-day trading, an increase of 57% from the average session volume of 8,176,589 shares. The stock had previously closed at $73.69.
The pharmacy operator reported $1.73 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.02. CVS Health had a return on equity of 18.25% and a net margin of 1.61%. The firm had revenue of $47.27 billion during the quarter, compared to the consensus estimate of $47.22 billion. During the same quarter in the prior year, the firm posted $1.50 EPS. The business’s revenue was up 2.4% on a year-over-year basis.
The company also recently declared a quarterly dividend, which was paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.57%. The ex-dividend date of this dividend was Tuesday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 33.90%.
A number of research firms have weighed in on CVS. ValuEngine raised CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday, October 11th. Royal Bank of Canada upped their price target on CVS Health to $101.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 18th. Bank of America upped their price target on CVS Health from $86.00 to $90.00 and gave the stock a “buy” rating in a research report on Monday, September 17th. Wolfe Research assumed coverage on CVS Health in a research report on Thursday, October 25th. They set a “peer perform” rating for the company. Finally, Tigress Financial reiterated a “buy” rating on shares of CVS Health in a research note on Friday, October 26th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $86.18.
In other news, EVP Lisa Bisaccia sold 21,534 shares of the company’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $80.00, for a total transaction of $1,722,720.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Kevin Hourican sold 8,564 shares of the company’s stock in a transaction that occurred on Monday, August 27th. The stock was sold at an average price of $75.00, for a total value of $642,300.00. Following the sale, the executive vice president now owns 12,135 shares in the company, valued at approximately $910,125. The disclosure for this sale can be found here. In the last quarter, insiders have sold 43,409 shares of company stock worth $3,392,097. Company insiders own 0.53% of the company’s stock.
Institutional investors have recently made changes to their positions in the company. BlackRock Inc. raised its stake in CVS Health by 5.9% in the 2nd quarter. BlackRock Inc. now owns 74,135,102 shares of the pharmacy operator’s stock valued at $4,770,597,000 after acquiring an additional 4,121,620 shares during the period. Charles Schwab Investment Advisory Inc. bought a new stake in CVS Health in the 2nd quarter valued at $190,701,000. Boston Partners raised its stake in CVS Health by 41.9% in the 2nd quarter. Boston Partners now owns 9,908,888 shares of the pharmacy operator’s stock valued at $637,637,000 after acquiring an additional 2,924,875 shares during the period. Morgan Stanley raised its stake in CVS Health by 28.4% in the 2nd quarter. Morgan Stanley now owns 8,358,263 shares of the pharmacy operator’s stock valued at $537,854,000 after acquiring an additional 1,848,678 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec raised its stake in CVS Health by 52.1% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 5,171,271 shares of the pharmacy operator’s stock valued at $332,771,000 after acquiring an additional 1,771,170 shares during the period. Institutional investors own 82.42% of the company’s stock.
The company has a quick ratio of 1.87, a current ratio of 2.34 and a debt-to-equity ratio of 1.73. The company has a market cap of $74.41 billion, a price-to-earnings ratio of 13.20, a price-to-earnings-growth ratio of 0.97 and a beta of 0.98.
WARNING: This piece was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/11/06/cvs-health-cvs-shares-up-5-7-on-earnings-beat.html.
About CVS Health (NYSE:CVS)
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Recommended Story: What kind of dividend yield to CEF’s pay?
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.